Markers of endothelial activation and atherothrombosis in women with history of preeclampsia or gestational hypertension

Thrombosis and Haemostasis

Volumn 90, Issue 6, 2003, Pages 1192-1197

  Vickers, Mark ^a   Ford, Isobel ^a   Morrison, Rona ^a   Prescott, Gordon ^a   Watson, Stuart ^a   Hannaford, Philip ^a   Smith, Cairns ^a   Campbell, Doris ^a   Greaves, Michael ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

C reactive protein; Fibrinogen; Preeclampsia; Vascular endothelium; Von Willebrand factor

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; MARKER; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ANGINA PECTORIS; ARTERY THROMBOSIS; ARTICLE; CELL ACTIVATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; ECLAMPSIA; ENDOTHELIUM LESION; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SMOKING; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

EID: 0346903154     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-01-0053     Document Type: Article

References (47)

1. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53-6.
2. Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. NEJM 2001; 344: 867-72.
3. Higgins JR, De Swiet M. Blood pressure measurement and classification in pregnancy. Lancet 2001; 357: 131-5.
4. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. In: Wynn R, ed. Obstetrics and Gynecology Annual 1979; 177-191.
5. Pijnenborg R, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynae 1991; 986: 48-55.
6. Taylor RN, et al. Selective effects of preeclamptic sera as human endothelial cell procoagulant protein expression. Am J Obst Gynecol 1991; 165: 1705-10.
7. Roberts JM. Endothelial dysfunction in pre-clampsia. Semin Reprod Endocrinol 1998; 16: 5-15.
8. Verhaar MC, Rabelink TJ. The endothelium: A gynecological and obstetric point of view. Eur J Obst Gyn & Reprod Biol 2001; 94: 180-5.
9. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-4.
10. Krauss T, et al. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obst Gynecol 1997; 177: 443-9.
11. Sibai BM. Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern-Fetal Med 2000; 9: 62-5.
12. Sugi T, Makino T. Autoantibodies to contact proteins in patients with recurrent pregnancy losses. J Reprod Immunol 2002; 53: 269-77
13. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999; 353: 1348-53.
14. Chesley LC, et al. The familial factor in toxemia of pregnancy. Obst Gynecol 1968; 32: 303-11.
15. Lachmeijer AM, Aarnoudse JE, Ten Kate LP, et al. Concordance for pre-eclampsia in monozygous twins. Br J Obstet Gynecol 1998; 105: 1315-7.
16. Thornton JG, Macdonald AM. Twin mothers, pregnancy hypertension and pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 570-5.
17. Ros HS, Lichtenstein P, Lipworth L, et al. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000; 91: 256-60.
18. Chesley LC, Annitto JE, Cosgrove RA. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1976; 124: 446-59.
19. Fisher KA, Luger A, Spargo BH, et al. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine 1981; 60: 267-76.
20. Jonsdottir LS, Arngrimsson R, Geirsson RT, et al. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74: 772-6.
21. Wilson BJ, Watson SM, Prescott GJ, et al. Hypertensive diseases of pregnancy and the risk of hypertension and stroke in later life. Br Med J 2003; 326: 845-9.
22. Fujimura Y, Titani K. 'Structure and Function of von Willebrand factor' in: AL Bloom, CD Forbes, DP Thomas, EGD Tuddenham - Haemostasis and Thrombosis, 3rd ed Churchill Livingstone, Edinburgh, UK: 379-96.
23. Mannucci PM. Von Willebrand factor: A marker of endothelial damage? Arterioscler, Thromb Vasc Biol 1998; 18: 1359-62.
24. Whincup PH, Danesh J, Walker M, et al. Von Willebrand factor and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2002; 23: 1764-70.
25. Kumari M, Marmot M, Brunner E. Social determinants of von Willebrand factor: The Whitehall II study. Arterioscler Thromb Vasc Biol 2000; 20: 1842-7.
26. Szalai AJ, Van Ginkel FW, Dalrymple SA, et al. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 1998; 160: 5294-5299.
27. Weinhold B, Bader A, Poli V, et al. Interleukin-6 is necessary, but not sufficient, for induction of the human C-reactive protein gene in vivo. Biochem J 1997; 325: 617-21.
28. Culley FJ, Bodman-Smith KB, Ferguson MA, et al. C-reactive protein binds to phosphorylated carbohydrates. Glycobiology. 2000; 10: 59-65.
29. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease: Meta-analysis of prospective studies. JAMA 1998; 279: 1477-82.
30. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 2000; 321: 199-204.
31. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-8.
32. Redman CW, Sacks GP, Sargent IL. Preeclampsia, an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499-506.
33. Ray A. A SAF binding site in the promoter region of human gamma-fibrinogen gene functions as an Il-6 response element. J Immunol 2000; 165: 3411-17.
34. Hutchinson WL, et al. Immunoradiometric assay of circulating C-reactive proteins: Age-related values in the adult general population. Clin Chem 2000; 46: 934-68.
35. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle aged and elderly US adults. NEJM 1997; 337: 1705-14.
36. Clausen T, Djurovic S, Brosstad FR, et al. Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: Indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000; 182: 321-5.
37. Chambers JC, Fusi L, Malik IS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001; 285: 1607-12.
38. Mayosi BM, Vickers MA, Green FR, et al. Evidence of a quantitative trait locus for plasma fibrinogen from a family-based association study. Genescreen 2001; 1: 151-5.
39. Vickers MA, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029-34.
40. Ross R. Atherosclerosis - An inflammatory disease. NEJM 1999; 340: 115-26.
41. Grandone E, et al. Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost 1999; 81: 349-52.
42. Morrison ER, Miedzybrodzka ZH, Campbell DM, et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: Results from a large population-based study and systematic review. Thromb Haemost 2002; 87: 779-85.
43. Kraaijenhagen RA, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83: 5-9.
44. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. NEJM 2000; 343: 457-62.
45. Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ, et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haem 2000; 109: 519-22.
46. Kamphuisen PW, Rosendaal FR, Eikenboom JC, et al. Factor V antigen levels and venous thrombosis: Risk profile, interaction with factor V Leiden and relation with factor VIII antigen levels. Arterioscler, Thromb Vasc Biol 2000; 20: 1382-6.
47. Imhof A, Froehlich M, Brenner H, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.